Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Vaccine|April 2, 2018
Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countriesGeorge Kassianos, Ernest Kuchar, Aneta Nitsch-Osuch, et al.
Heliyon|November 15, 2023
Effective criteria in the public-private partnership in developing countries to apply the sustainable development goals: GAN-based decision support system for the renewable electrical system, case study SyriaVladimír Krepl, Ghaeth Fandi, Mohammad Rehabi, et al.
BMC Infectious Diseases|May 16, 2019
Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance NetworkJoan Puig-Barberà, Ainara Mira-Iglesias, Elena Burtseva, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|July 1, 2024
Effectiveness of Vaccination Against Tick-Borne Encephalitis in the Czech Republic, 2018-2022Jan Kyncl, Frederick J Angulo, Hana Orlikova, et al.
Human Vaccines & Immunotherapeutics|June 21, 2018
Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years laterPatricia R Blank, Gerrit Adrianus van Essen, Raúl Ortiz de Lejarazu, et al.
BMC Infectious Diseases|July 4, 2020
Complicated hospitalization due to influenza: results from the Global Hospital Influenza Network for the 2017-2018 seasonBruno Lina, Alexandre Georges, Elena Burtseva, et al.
BMC Public Health|May 4, 2019
Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)Víctor Baselga-Moreno, Svetlana Trushakova, Shelly McNeil, et al.
Germs|January 8, 2025
Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024"George Kassianos, Rok Civljak, Gerrit Adrianus van Essen, et al.
Ticks and Tick-Borne Diseases|December 21, 2024
Evaluating the need for standardised disease manifestation categories in patients infected with the tick-borne encephalitis virus: A Delphi panelKate Halsby, Gerhard Dobler, Ava Easton, et al.
Expert Review of Respiratory Medicine|April 23, 2024
The influenza landscape and vaccination coverage in older adults during the SARS-Cov-2 pandemic: data from Several European Countries and IsraelGeorge Kassianos, Jean-Marie Cohen, Rok Civljak, et al.
Pageof 3